Latest news
Loading news…
Oncimmune
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Nottingham, United Kingdom Founded 2006 51-100 employees For Profit
Oncimmune is a scientific company that engages in developing and commercializing its EarlyCDT platform technology.
Oncimmune was acquired by Freenome in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
38
Ticker
ONC
LSE - London Stock Exchange
Patents
0
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ONC
- Exchange
- LSE - London Stock Exchange
- IPO date
- Mar 18, 2016
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 22
- Patents granted
- 0
- Trademarks
- 6
- IT spend
- $2M
Company Info
- Founded
- 2006
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 39
- HQ
- Nottingham, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Mar 18, 2016
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.2
- Trend (90d)
- 1.3
- Last leadership hire
- Jul 12, 2023
Acquisitions by Oncimmune
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Oncimmune
Chief executive officer
38
professional contacts at Oncimmune
Contact execs at Oncimmune →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Oncimmune
Loading news…
FAQs about Oncimmune
People who checked this page also checked these
Sectors Oncimmune invests & acquires in
Browse the full Acquirezy directory.